Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Champions Oncology (CSBR) Accumulated Depreciation & Amortization (2016 - 2026)

Champions Oncology (CSBR) has 14 years of Accumulated Depreciation & Amortization data on record, last reported at $715000.0 in Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 15.68% year-over-year to $715000.0; the TTM value through Oct 2025 reached $715000.0, down 15.68%, while the annual FY2025 figure was $1.6 million, 12.16% down from the prior year.
  • Accumulated Depreciation & Amortization reached $715000.0 in Q4 2025 per CSBR's latest filing, up from $358000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $2.2 million in Q2 2023 and bottomed at $279000.0 in Q1 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $1.0 million, with a median of $994000.0 recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: tumbled 51.81% in 2021, then soared 279.57% in 2022.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $663000.0 in 2021, then soared by 64.1% to $1.1 million in 2022, then dropped by 14.61% to $929000.0 in 2023, then dropped by 8.72% to $848000.0 in 2024, then fell by 15.68% to $715000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $715000.0 in Q4 2025, $358000.0 in Q3 2025, and $1.6 million in Q2 2025.